Novartis Ag (NVS) Total Non-Current Liabilities (2009 - 2026)

Novartis Ag (NVS) has 15 years of Total Non-Current Liabilities data on file, last reported at $100.0 million in Q1 2026.

• Quarterly Total Non-Current Liabilities changed N/A year-over-year to $100.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $100.0 million (changed N/A YoY) and the FY2025 annual result came in at $37.1 billion, up 26.15% from the prior year.
• Total Non-Current Liabilities fell to $100.0 million in Q1 2026 per NVS's latest filing, from $37.1 billion in the prior quarter.
• The five-year high for Total Non-Current Liabilities was $37.1 billion in Q4 2025, with the low at $100.0 million in Q1 2026.
• Average Total Non-Current Liabilities over 5 years is $24.1 billion, with a median of $28.7 billion recorded in 2022.
• Year-over-year, Total Non-Current Liabilities soared 51.45% in 2022 and slipped 15.87% in 2023.
• Novartis Ag's Total Non-Current Liabilities stood at $29.4 billion in 2022, then declined by 8.75% to $26.8 billion in 2023, then increased by 9.79% to $29.4 billion in 2024, then climbed by 26.15% to $37.1 billion in 2025, then slumped by 99.73% to $100.0 million in 2026.
• Business Quant data shows NVS's Total Non-Current Liabilities at $100.0 million in Q1 2026, $37.1 billion in Q4 2025, and $30.6 billion in Q2 2025.